[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Cancer Early Detection and Screening Market Growth (Status and Outlook) 2023-2029

June 2023 | 100 pages | ID: G852A83D926CEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The global Cancer Early Detection and Screening market size is projected to grow from US$ 240.6 million in 2022 to US$ 374.8 million in 2029; it is expected to grow at a CAGR of 6.5% from 2023 to 2029.

United States market for Cancer Early Detection and Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Cancer Early Detection and Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Cancer Early Detection and Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Cancer Early Detection and Screening players cover Exact Sciences, Grail, Genetron Health, New Horizon Health, Burning Rock, Berry Oncology, Shanghai Kunyuan Biotechnology, Oncognostic and Epigenomics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Cancer early detection and diagnosis are crucial in improving treatment outcomes and patient survival rates. Early detection involves identifying cancer at its earliest stages, even before symptoms become apparent.

LPI (LP Information)' newest research report, the “Cancer Early Detection and Screening Industry Forecast” looks at past sales and reviews total world Cancer Early Detection and Screening sales in 2022, providing a comprehensive analysis by region and market sector of projected Cancer Early Detection and Screening sales for 2023 through 2029. With Cancer Early Detection and Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cancer Early Detection and Screening industry.

This Insight Report provides a comprehensive analysis of the global Cancer Early Detection and Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cancer Early Detection and Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cancer Early Detection and Screening market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cancer Early Detection and Screening and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cancer Early Detection and Screening.

This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Early Detection and Screening market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
  • Colorectal Cancer
  • Liver Cancer
  • Lung Cancer
  • Other
Segmentation by application
  • Hospital
  • Medical Center
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Exact Sciences
  • Grail
  • Genetron Health
  • New Horizon Health
  • Burning Rock
  • Berry Oncology
  • Shanghai Kunyuan Biotechnology
  • Oncognostic
  • Epigenomics
  • Abbott
  • Qiagen
  • iStat Biomedical
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cancer Early Detection and Screening Market Size 2018-2029
  2.1.2 Cancer Early Detection and Screening Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cancer Early Detection and Screening Segment by Type
  2.2.1 Colorectal Cancer
  2.2.2 Liver Cancer
  2.2.3 Lung Cancer
  2.2.4 Other
2.3 Cancer Early Detection and Screening Market Size by Type
  2.3.1 Cancer Early Detection and Screening Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Cancer Early Detection and Screening Market Size Market Share by Type (2018-2023)
2.4 Cancer Early Detection and Screening Segment by Application
  2.4.1 Hospital
  2.4.2 Medical Center
  2.4.3 Other
2.5 Cancer Early Detection and Screening Market Size by Application
  2.5.1 Cancer Early Detection and Screening Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Cancer Early Detection and Screening Market Size Market Share by Application (2018-2023)

3 CANCER EARLY DETECTION AND SCREENING MARKET SIZE BY PLAYER

3.1 Cancer Early Detection and Screening Market Size Market Share by Players
  3.1.1 Global Cancer Early Detection and Screening Revenue by Players (2018-2023)
  3.1.2 Global Cancer Early Detection and Screening Revenue Market Share by Players (2018-2023)
3.2 Global Cancer Early Detection and Screening Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CANCER EARLY DETECTION AND SCREENING BY REGIONS

4.1 Cancer Early Detection and Screening Market Size by Regions (2018-2023)
4.2 Americas Cancer Early Detection and Screening Market Size Growth (2018-2023)
4.3 APAC Cancer Early Detection and Screening Market Size Growth (2018-2023)
4.4 Europe Cancer Early Detection and Screening Market Size Growth (2018-2023)
4.5 Middle East & Africa Cancer Early Detection and Screening Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Cancer Early Detection and Screening Market Size by Country (2018-2023)
5.2 Americas Cancer Early Detection and Screening Market Size by Type (2018-2023)
5.3 Americas Cancer Early Detection and Screening Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Cancer Early Detection and Screening Market Size by Region (2018-2023)
6.2 APAC Cancer Early Detection and Screening Market Size by Type (2018-2023)
6.3 APAC Cancer Early Detection and Screening Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Cancer Early Detection and Screening by Country (2018-2023)
7.2 Europe Cancer Early Detection and Screening Market Size by Type (2018-2023)
7.3 Europe Cancer Early Detection and Screening Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cancer Early Detection and Screening by Region (2018-2023)
8.2 Middle East & Africa Cancer Early Detection and Screening Market Size by Type (2018-2023)
8.3 Middle East & Africa Cancer Early Detection and Screening Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CANCER EARLY DETECTION AND SCREENING MARKET FORECAST

10.1 Global Cancer Early Detection and Screening Forecast by Regions (2024-2029)
  10.1.1 Global Cancer Early Detection and Screening Forecast by Regions (2024-2029)
  10.1.2 Americas Cancer Early Detection and Screening Forecast
  10.1.3 APAC Cancer Early Detection and Screening Forecast
  10.1.4 Europe Cancer Early Detection and Screening Forecast
  10.1.5 Middle East & Africa Cancer Early Detection and Screening Forecast
10.2 Americas Cancer Early Detection and Screening Forecast by Country (2024-2029)
  10.2.1 United States Cancer Early Detection and Screening Market Forecast
  10.2.2 Canada Cancer Early Detection and Screening Market Forecast
  10.2.3 Mexico Cancer Early Detection and Screening Market Forecast
  10.2.4 Brazil Cancer Early Detection and Screening Market Forecast
10.3 APAC Cancer Early Detection and Screening Forecast by Region (2024-2029)
  10.3.1 China Cancer Early Detection and Screening Market Forecast
  10.3.2 Japan Cancer Early Detection and Screening Market Forecast
  10.3.3 Korea Cancer Early Detection and Screening Market Forecast
  10.3.4 Southeast Asia Cancer Early Detection and Screening Market Forecast
  10.3.5 India Cancer Early Detection and Screening Market Forecast
  10.3.6 Australia Cancer Early Detection and Screening Market Forecast
10.4 Europe Cancer Early Detection and Screening Forecast by Country (2024-2029)
  10.4.1 Germany Cancer Early Detection and Screening Market Forecast
  10.4.2 France Cancer Early Detection and Screening Market Forecast
  10.4.3 UK Cancer Early Detection and Screening Market Forecast
  10.4.4 Italy Cancer Early Detection and Screening Market Forecast
  10.4.5 Russia Cancer Early Detection and Screening Market Forecast
10.5 Middle East & Africa Cancer Early Detection and Screening Forecast by Region (2024-2029)
  10.5.1 Egypt Cancer Early Detection and Screening Market Forecast
  10.5.2 South Africa Cancer Early Detection and Screening Market Forecast
  10.5.3 Israel Cancer Early Detection and Screening Market Forecast
  10.5.4 Turkey Cancer Early Detection and Screening Market Forecast
  10.5.5 GCC Countries Cancer Early Detection and Screening Market Forecast
10.6 Global Cancer Early Detection and Screening Forecast by Type (2024-2029)
10.7 Global Cancer Early Detection and Screening Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Exact Sciences
  11.1.1 Exact Sciences Company Information
  11.1.2 Exact Sciences Cancer Early Detection and Screening Product Offered
  11.1.3 Exact Sciences Cancer Early Detection and Screening Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Exact Sciences Main Business Overview
  11.1.5 Exact Sciences Latest Developments
11.2 Grail
  11.2.1 Grail Company Information
  11.2.2 Grail Cancer Early Detection and Screening Product Offered
  11.2.3 Grail Cancer Early Detection and Screening Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Grail Main Business Overview
  11.2.5 Grail Latest Developments
11.3 Genetron Health
  11.3.1 Genetron Health Company Information
  11.3.2 Genetron Health Cancer Early Detection and Screening Product Offered
  11.3.3 Genetron Health Cancer Early Detection and Screening Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Genetron Health Main Business Overview
  11.3.5 Genetron Health Latest Developments
11.4 New Horizon Health
  11.4.1 New Horizon Health Company Information
  11.4.2 New Horizon Health Cancer Early Detection and Screening Product Offered
  11.4.3 New Horizon Health Cancer Early Detection and Screening Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 New Horizon Health Main Business Overview
  11.4.5 New Horizon Health Latest Developments
11.5 Burning Rock
  11.5.1 Burning Rock Company Information
  11.5.2 Burning Rock Cancer Early Detection and Screening Product Offered
  11.5.3 Burning Rock Cancer Early Detection and Screening Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Burning Rock Main Business Overview
  11.5.5 Burning Rock Latest Developments
11.6 Berry Oncology
  11.6.1 Berry Oncology Company Information
  11.6.2 Berry Oncology Cancer Early Detection and Screening Product Offered
  11.6.3 Berry Oncology Cancer Early Detection and Screening Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Berry Oncology Main Business Overview
  11.6.5 Berry Oncology Latest Developments
11.7 Shanghai Kunyuan Biotechnology
  11.7.1 Shanghai Kunyuan Biotechnology Company Information
  11.7.2 Shanghai Kunyuan Biotechnology Cancer Early Detection and Screening Product Offered
  11.7.3 Shanghai Kunyuan Biotechnology Cancer Early Detection and Screening Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Shanghai Kunyuan Biotechnology Main Business Overview
  11.7.5 Shanghai Kunyuan Biotechnology Latest Developments
11.8 Oncognostic
  11.8.1 Oncognostic Company Information
  11.8.2 Oncognostic Cancer Early Detection and Screening Product Offered
  11.8.3 Oncognostic Cancer Early Detection and Screening Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Oncognostic Main Business Overview
  11.8.5 Oncognostic Latest Developments
11.9 Epigenomics
  11.9.1 Epigenomics Company Information
  11.9.2 Epigenomics Cancer Early Detection and Screening Product Offered
  11.9.3 Epigenomics Cancer Early Detection and Screening Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Epigenomics Main Business Overview
  11.9.5 Epigenomics Latest Developments
11.10 Abbott
  11.10.1 Abbott Company Information
  11.10.2 Abbott Cancer Early Detection and Screening Product Offered
  11.10.3 Abbott Cancer Early Detection and Screening Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 Abbott Main Business Overview
  11.10.5 Abbott Latest Developments
11.11 Qiagen
  11.11.1 Qiagen Company Information
  11.11.2 Qiagen Cancer Early Detection and Screening Product Offered
  11.11.3 Qiagen Cancer Early Detection and Screening Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 Qiagen Main Business Overview
  11.11.5 Qiagen Latest Developments
11.12 iStat Biomedical
  11.12.1 iStat Biomedical Company Information
  11.12.2 iStat Biomedical Cancer Early Detection and Screening Product Offered
  11.12.3 iStat Biomedical Cancer Early Detection and Screening Revenue, Gross Margin and Market Share (2018-2023)
  11.12.4 iStat Biomedical Main Business Overview
  11.12.5 iStat Biomedical Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Cancer Early Detection and Screening Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Colorectal Cancer
Table 3. Major Players of Liver Cancer
Table 4. Major Players of Lung Cancer
Table 5. Major Players of Other
Table 6. Cancer Early Detection and Screening Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Cancer Early Detection and Screening Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Cancer Early Detection and Screening Market Size Market Share by Type (2018-2023)
Table 9. Cancer Early Detection and Screening Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Cancer Early Detection and Screening Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Cancer Early Detection and Screening Market Size Market Share by Application (2018-2023)
Table 12. Global Cancer Early Detection and Screening Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Cancer Early Detection and Screening Revenue Market Share by Player (2018-2023)
Table 14. Cancer Early Detection and Screening Key Players Head office and Products Offered
Table 15. Cancer Early Detection and Screening Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Cancer Early Detection and Screening Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Cancer Early Detection and Screening Market Size Market Share by Regions (2018-2023)
Table 20. Global Cancer Early Detection and Screening Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Cancer Early Detection and Screening Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Cancer Early Detection and Screening Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Cancer Early Detection and Screening Market Size Market Share by Country (2018-2023)
Table 24. Americas Cancer Early Detection and Screening Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Cancer Early Detection and Screening Market Size Market Share by Type (2018-2023)
Table 26. Americas Cancer Early Detection and Screening Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Cancer Early Detection and Screening Market Size Market Share by Application (2018-2023)
Table 28. APAC Cancer Early Detection and Screening Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Cancer Early Detection and Screening Market Size Market Share by Region (2018-2023)
Table 30. APAC Cancer Early Detection and Screening Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Cancer Early Detection and Screening Market Size Market Share by Type (2018-2023)
Table 32. APAC Cancer Early Detection and Screening Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Cancer Early Detection and Screening Market Size Market Share by Application (2018-2023)
Table 34. Europe Cancer Early Detection and Screening Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Cancer Early Detection and Screening Market Size Market Share by Country (2018-2023)
Table 36. Europe Cancer Early Detection and Screening Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Cancer Early Detection and Screening Market Size Market Share by Type (2018-2023)
Table 38. Europe Cancer Early Detection and Screening Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Cancer Early Detection and Screening Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Cancer Early Detection and Screening Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Cancer Early Detection and Screening Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Cancer Early Detection and Screening Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Cancer Early Detection and Screening Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Cancer Early Detection and Screening Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Cancer Early Detection and Screening Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Cancer Early Detection and Screening
Table 47. Key Market Challenges & Risks of Cancer Early Detection and Screening
Table 48. Key Industry Trends of Cancer Early Detection and Screening
Table 49. Global Cancer Early Detection and Screening Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Cancer Early Detection and Screening Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Cancer Early Detection and Screening Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Cancer Early Detection and Screening Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Exact Sciences Details, Company Type, Cancer Early Detection and Screening Area Served and Its Competitors
Table 54. Exact Sciences Cancer Early Detection and Screening Product Offered
Table 55. Exact Sciences Cancer Early Detection and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Exact Sciences Main Business
Table 57. Exact Sciences Latest Developments
Table 58. Grail Details, Company Type, Cancer Early Detection and Screening Area Served and Its Competitors
Table 59. Grail Cancer Early Detection and Screening Product Offered
Table 60. Grail Main Business
Table 61. Grail Cancer Early Detection and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Grail Latest Developments
Table 63. Genetron Health Details, Company Type, Cancer Early Detection and Screening Area Served and Its Competitors
Table 64. Genetron Health Cancer Early Detection and Screening Product Offered
Table 65. Genetron Health Main Business
Table 66. Genetron Health Cancer Early Detection and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Genetron Health Latest Developments
Table 68. New Horizon Health Details, Company Type, Cancer Early Detection and Screening Area Served and Its Competitors
Table 69. New Horizon Health Cancer Early Detection and Screening Product Offered
Table 70. New Horizon Health Main Business
Table 71. New Horizon Health Cancer Early Detection and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. New Horizon Health Latest Developments
Table 73. Burning Rock Details, Company Type, Cancer Early Detection and Screening Area Served and Its Competitors
Table 74. Burning Rock Cancer Early Detection and Screening Product Offered
Table 75. Burning Rock Main Business
Table 76. Burning Rock Cancer Early Detection and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Burning Rock Latest Developments
Table 78. Berry Oncology Details, Company Type, Cancer Early Detection and Screening Area Served and Its Competitors
Table 79. Berry Oncology Cancer Early Detection and Screening Product Offered
Table 80. Berry Oncology Main Business
Table 81. Berry Oncology Cancer Early Detection and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Berry Oncology Latest Developments
Table 83. Shanghai Kunyuan Biotechnology Details, Company Type, Cancer Early Detection and Screening Area Served and Its Competitors
Table 84. Shanghai Kunyuan Biotechnology Cancer Early Detection and Screening Product Offered
Table 85. Shanghai Kunyuan Biotechnology Main Business
Table 86. Shanghai Kunyuan Biotechnology Cancer Early Detection and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Shanghai Kunyuan Biotechnology Latest Developments
Table 88. Oncognostic Details, Company Type, Cancer Early Detection and Screening Area Served and Its Competitors
Table 89. Oncognostic Cancer Early Detection and Screening Product Offered
Table 90. Oncognostic Main Business
Table 91. Oncognostic Cancer Early Detection and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Oncognostic Latest Developments
Table 93. Epigenomics Details, Company Type, Cancer Early Detection and Screening Area Served and Its Competitors
Table 94. Epigenomics Cancer Early Detection and Screening Product Offered
Table 95. Epigenomics Main Business
Table 96. Epigenomics Cancer Early Detection and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Epigenomics Latest Developments
Table 98. Abbott Details, Company Type, Cancer Early Detection and Screening Area Served and Its Competitors
Table 99. Abbott Cancer Early Detection and Screening Product Offered
Table 100. Abbott Main Business
Table 101. Abbott Cancer Early Detection and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Abbott Latest Developments
Table 103. Qiagen Details, Company Type, Cancer Early Detection and Screening Area Served and Its Competitors
Table 104. Qiagen Cancer Early Detection and Screening Product Offered
Table 105. Qiagen Cancer Early Detection and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Qiagen Main Business
Table 107. Qiagen Latest Developments
Table 108. iStat Biomedical Details, Company Type, Cancer Early Detection and Screening Area Served and Its Competitors
Table 109. iStat Biomedical Cancer Early Detection and Screening Product Offered
Table 110. iStat Biomedical Main Business
Table 111. iStat Biomedical Cancer Early Detection and Screening Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. iStat Biomedical Latest Developments

LIST OF FIGURES

Figure 1. Cancer Early Detection and Screening Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cancer Early Detection and Screening Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Cancer Early Detection and Screening Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Cancer Early Detection and Screening Sales Market Share by Country/Region (2022)
Figure 8. Cancer Early Detection and Screening Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Cancer Early Detection and Screening Market Size Market Share by Type in 2022
Figure 10. Cancer Early Detection and Screening in Hospital
Figure 11. Global Cancer Early Detection and Screening Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Cancer Early Detection and Screening in Medical Center
Figure 13. Global Cancer Early Detection and Screening Market: Medical Center (2018-2023) & ($ Millions)
Figure 14. Cancer Early Detection and Screening in Other
Figure 15. Global Cancer Early Detection and Screening Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Cancer Early Detection and Screening Market Size Market Share by Application in 2022
Figure 17. Global Cancer Early Detection and Screening Revenue Market Share by Player in 2022
Figure 18. Global Cancer Early Detection and Screening Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Cancer Early Detection and Screening Market Size 2018-2023 ($ Millions)
Figure 20. APAC Cancer Early Detection and Screening Market Size 2018-2023 ($ Millions)
Figure 21. Europe Cancer Early Detection and Screening Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Cancer Early Detection and Screening Market Size 2018-2023 ($ Millions)
Figure 23. Americas Cancer Early Detection and Screening Value Market Share by Country in 2022
Figure 24. United States Cancer Early Detection and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Cancer Early Detection and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Cancer Early Detection and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Cancer Early Detection and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Cancer Early Detection and Screening Market Size Market Share by Region in 2022
Figure 29. APAC Cancer Early Detection and Screening Market Size Market Share by Type in 2022
Figure 30. APAC Cancer Early Detection and Screening Market Size Market Share by Application in 2022
Figure 31. China Cancer Early Detection and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Cancer Early Detection and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Cancer Early Detection and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Cancer Early Detection and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Cancer Early Detection and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Cancer Early Detection and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Cancer Early Detection and Screening Market Size Market Share by Country in 2022
Figure 38. Europe Cancer Early Detection and Screening Market Size Market Share by Type (2018-2023)
Figure 39. Europe Cancer Early Detection and Screening Market Size Market Share by Application (2018-2023)
Figure 40. Germany Cancer Early Detection and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Cancer Early Detection and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Cancer Early Detection and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Cancer Early Detection and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Cancer Early Detection and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Cancer Early Detection and Screening Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Cancer Early Detection and Screening Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Cancer Early Detection and Screening Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Cancer Early Detection and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Cancer Early Detection and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Cancer Early Detection and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Cancer Early Detection and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Cancer Early Detection and Screening Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Cancer Early Detection and Screening Market Size 2024-2029 ($ Millions)
Figure 54. APAC Cancer Early Detection and Screening Market Size 2024-2029 ($ Millions)
Figure 55. Europe Cancer Early Detection and Screening Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Cancer Early Detection and Screening Market Size 2024-2029 ($ Millions)
Figure 57. United States Cancer Early Detection and Screening Market Size 2024-2029 ($ Millions)
Figure 58. Canada Cancer Early Detection and Screening Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Cancer Early Detection and Screening Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Cancer Early Detection and Screening Market Size 2024-2029 ($ Millions)
Figure 61. China Cancer Early Detection and Screening Market Size 2024-2029 ($ Millions)
Figure 62. Japan Cancer Early Detection and Screening Market Size 2024-2029 ($ Millions)
Figure 63. Korea Cancer Early Detection and Screening Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Cancer Early Detection and Screening Market Size 2024-2029 ($ Millions)
Figure 65. India Cancer Early Detection and Screening Market Size 2024-2029 ($ Millions)
Figure 66. Australia Cancer Early Detection and Screening Market Size 2024-2029 ($ Millions)
Figure 67. Germany Cancer Early Detection and Screening Market Size 2024-2029 ($ Millions)
Figure 68. France Cancer Early Detection and Screening Market Size 2024-2029 ($ Millions)
Figure 69. UK Cancer Early Detection and Screening Market Size 2024-2029 ($ Millions)
Figure 70. Italy Cancer Early Detection and Screening Market Size 2024-2029 ($ Millions)
Figure 71. Russia Cancer Early Detection and Screening Market Size 2024-2029 ($ Millions)
Figure 72. Spain Cancer Early Detection and Screening Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Cancer Early Detection and Screening Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Cancer Early Detection and Screening Market Size 2024-2029 ($ Millions)
Figure 75. Israel Cancer Early Detection and Screening Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Cancer Early Detection and Screening Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Cancer Early Detection and Screening Market Size 2024-2029 ($ Millions)
Figure 78. Global Cancer Early Detection and Screening Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Cancer Early Detection and Screening Market Size Market Share Forecast by Application (2024-2029)


More Publications